返回

Quantum BioPharma applies to delist Class B shares from CSE

正在验证中
  • Quantum BioPharma applied to voluntarily delist Class B shares from the CSE.
  • September 4, 2026, is expected to be the final CSE trading day, pending approval.
  • Class B shares will continue trading on Nasdaq, the Frankfurt Stock Exchange and Upstream.
本网站上的信息是使用AI生成的，我们无法保证其准确性。 请仅作为参考信息使用。